Kewaunee Scientific Corporation
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.3% | +21.2% | -14.7% | -1.3% | +40.6% | +14.9% | -7.8% | -1.4% | -1.0% | +2.9% | -7.1% | – | |
| – | -6.0% | +21.0% | -14.6% | -5.8% | +44.3% | +8.9% | -5.5% | +0.4% | +0.9% | -1.4% | -6.9% | – | |
| – | -10.7% | +21.7% | -14.7% | +11.7% | +31.7% | +30.8% | -12.9% | -5.8% | -6.0% | +14.6% | -7.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.5% | +9,790.2% | – | – | – | – | – | – | – | – | – | – | |
| – | -2.1% | +10.4% | +9.1% | -4.0% | +69.5% | -3.7% | +3.7% | -3.1% | +2.2% | +0.4% | +2.8% | – | |
| – | -25.5% | +46.0% | -53.7% | +72.2% | -49.3% | +277.8% | -43.4% | -14.6% | -37.1% | +102.0% | -39.5% | – | |
| – | +10.5% | +42.6% | -19.5% | -6.4% | +157.2% | +2.3% | -9.0% | +0.3% | +4.8% | -43.3% | -0.8% | – | |
| – | -27.5% | -61.7% | +80.4% | +61.8% | -67.6% | +460.7% | -45.2% | -11.9% | -53.5% | +196.5% | -46.2% | – | |
| – | -51.3% | -1,101.2% | – | +377.1% | -111.8% | – | -65.4% | +20.2% | -42.3% | +101.5% | -32.6% | – | |
| – | -7.7% | +337.4% | -80.1% | +37.2% | -55.0% | +258.2% | -36.2% | -21.0% | -71.7% | +389.6% | -49.6% | – | |
| – | -11.5% | -49.3% | +60.0% | +39.3% | -23.2% | +148.7% | -34.0% | -6.6% | -29.2% | +61.0% | -31.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.